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Abstract 
Depression has been linked to poor health outcome in a number 
of studies; however, the mechanism underlying this relationship 
has received little attention. This paper explores the possibility that 
adherence mediates the relationship between depression and 
outcome. Principal findings regarding the relationship between 
depression, adherence, and outcome are reviewed. The data 
suggest that depression is related, at least moderately, to poorer 
adherence to a variety of treatment components. The relationship 
between adherence and outcome is more difficult to establish. In 
addition, current data, albeit limited, do not support the hypothesis 
that adherence mediates the relationship between depression and 
outcome. An alternative model in which adherence precedes and 
influences both mood state and health outcome is discussed. 
Finally, possible explanations for these relationships are explored 
and suggestions for future research provided.   
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Introduction 
Depression has been associated with poor health out­
comes in a variety of medical conditions. For example, 
depression has been linked to higher glycosylated hemo­
globin in both type 1 and type 2 diabetes mellitus [1]. An 
important issue is to determine the mechanism underlying 
this relationship. One possibility, considered here, is that 
depressed patients are less adherent to their treatment 
regimens, and this lack of adherence produces poorer health 
outcomes (Fig. 1). 
Studies of the relationship between depression and 
adherence have used a variety of approaches to assess 
depression or depressive symptomatology (ranging from 
questionnaires, such as the Center for Epidemiologic 
Studies-Depression questionnaire or the Beck Depression 
Inventory, to clinical interviews). Likewise, different 
aspects of adherence (adherence to diet, exercise, glucose 
monitoring, medication adherence, attendance at treatment 
sessions), different criteria for defining adherence, and 
different approaches to measuring adherence have been 
used. While acknowledging that these methodological 
differences may affect results, and recognizing that adherence 
to one aspect of the regimen may be unrelated to adherence to 
other aspects [2], we have focussed this paper on some of the 
general and consistent findings regarding the relationship 
between depression, adherence, and outcome. We have also 
considered other possible interrelationships among these 
variables, using exercise and obesity as examples. 
The term ‘‘adherence’’ is used in preference to the term 
‘‘compliance’’ throughout the paper to recognize the import­
ance of the partnership between patient and provider in all 
aspects of medical care. 
Does depression affect adherence? 
Many studies have examined the association between 
depression and treatment adherence. It is well recognized 
that adherence to pharmacologic regimens for depression is 
very poor, with only 40% of those receiving an antidepres­
sant prescription completing the 9-month recommended 
treatment [3]. Adherence to medical regimens is also poor 
in depressed patients. A meta-analysis of this literature 
included 12 studies published from 1968 to 1998 that 
measured depression and adherence to a medical regimen 
recommended by a nonpsychiatrist physician [4]. Six of 
these studies involved patients with end-stage renal disease 
Fig. 1. Model showing adherence as the mediator of the relationship 
between depression and health outcome. 
or renal transplants and six involved other medical diseases 
(angina, cancer, arthritis). The relationship between depres­
sion and nonadherence was found to be consistent across 
studies and of moderate size (Table 1). The odds that an 
individual would be nonadherent were three times greater 
for depressed patients than for nondepressed patients. In 
contrast, this meta-analysis found no consistent relationship 
between anxiety and treatment adherence. 
Two recent studies reinforce this finding. In one study 
[5], 204 patients were interviewed for depression 3–5 days 
after a myocardial infarction and then re-contacted 4 months 
later to assess adherence to cardiac risk reduction recom­
mendations. Patients who reported no current mood disorder 
were compared to those with major depression/dysthymia 
(based on the Structured Clinical Interview for Axis I 
Disorders). The depressed patients reported lower adherence 
to several aspects of the regimen, including exercise, low-fat 
diet, stress reduction, and prescription medication. No 
differences were observed for other aspects of the regimen 
such as stopping smoking, following a low sodium diet, or 
carrying medical supplies. 
Another study [6] included 367 patients with diabetes 
who were seen in primary care clinics of a large health 
maintenance organization. Depressive symptoms were 
assessed with the Hopkins Symptom Checklist—90 Re­
vised; adherence was assessed by self-report and by using 
an automated data collection system for refills of hypogly­
cemic medication. Higher levels of depressive symptoms 
were associated with poorer adherence to the diet (amount 
and type of food) and with more days of interruption of 
hypoglycemic medication therapy. There was no association 
between depressive symptom severity and self-reported 
adherence to exercise or glucose monitoring. 
Thus, depression appears to be related, at least moder­
ately, to poorer adherence to a variety of treatment compo­
nents. It is now important to better understand why 
depressed patients are less adherent. There are a variety of 
possible explanations. Depressed patients report greater 
feelings of hopelessness (and thus may not expect treatment 
to be effective). They are often more socially isolated and 
social support has been related to adherence. Cognitive 
impairment in depressed patients may affect their memory 
of the health care prescriptions and recommendations given 
by the physician. Finally, depressed patients may not have 
the energy to carry out treatment recommendations. 
It is also important to consider whether the strength of the 
association between depression and adherence is due, in 
part, to a methodological artifact. When asked to self-report 
their level of adherence, depressed patients may have poor 
self-perceptions and underestimate their actual level of 
adherence. Thus, it is particularly important to use objective 
measures of adherence (such as pill counts or pharmacy 
records as used in the Ciechanowski study [6]) in assessing 
the relationship between depression and adherence. Further 
research is needed to better understand why depressed 
patients are less adherent in order to develop effective 
approaches to enhance adherence. 
Does adherence affect outcome? 
The model described in Fig. 1 assumes that depression 
affects adherence and that adherence affects outcome. There 
is a large literature studying the effect of adherence on 
outcome, which will not be reviewed in detail here. In 
general, however, it appears that adherence to medication is 
related to outcome. A recent review [7] assessed the rela­
tionship between medication adherence and morbidity and 
mortality in patients who were at risk for coronary artery 
disease and congestive heart failure. Seven of 12 studies that 
compared hospitalization rates and mortality in adherent and 
nonadherent patients showed significant differences. Of 
particular note is the fact that adherence to placebo is also 
related to outcome. 
It is more difficult to establish the relationship between 
adherence to behavioral recommendations and outcome. For 
example, in some weight loss studies, there are significant 
differences in weight loss between groups but no differences 
in dietary intake or exercise. This most likely reflects the 
difficulty in accurately measuring dietary intake and phys­
ical activity. Alternatively, the behaviors being studied may 
not be the behaviors that relate directly to outcome. For 
example, there may be little or no relationship between 
frequency of self-monitoring of blood glucose (SMBG) and 
glycosylated hemoglobin because the important behavior is 
not merely monitoring glucose levels but rather using the 
SMBG information to make adjustments in other aspects of 
the regimen. 
Does poor adherence mediate the relationship between 
depression and outcome? 
The question of whether adherence mediates the rela­
tionship between depression and outcome of diabetes, 
Table 1 
Meta-analysis of the relationship between depression and adherence 
Psychological variable Number of studies Unweighted Effect size 
Depression (Total) 12 � 0.27 P < .001 
ESRD 6 � 0.30 P =.008 
Non-ESRD 6 � 0.25 P =.005 
Anxiety (Total) 13 � 0.04 P =.59 
Ref. [4]. 
obesity, or renal disease has received little empirical study. 
One approach to this question is to determine whether the 
association between depression and outcome is weakened 
or becomes nonsignificant after adjusting for level of 
adherence. Gary et al. [8] found that depressive symp­
tomatology was associated with higher cholesterol, trigly­
cerides, and glycosylated hemoglobin levels in Type 2 
diabetic patients. Patients were asked to rate their adher­
ence to various aspects of the diabetes regimen on four-
point scales. Adjusting for level of adherence to diet, 
physical activity, smoking, glucose monitoring, and dia­
betes medication adherence did not reduce the effect of 
depression on these physiological outcome variables. Thus, 
this study provided no evidence that adherence mediated 
the relation between depression and outcome. 
Another approach to determining whether adherence 
mediates the relationship between depression and outcome 
is to examine whether interventions that reduce depression 
and produce improvements in health outcome are associ­
ated with improvements in adherence. (If so, analyses 
adjusting for the improvement in adherence should reduce 
the association between changes in depression and changes 
in outcome.) Lustman et al. have conducted two interven­
tion studies with depressed patients with diabetes; one 
study used an antidepressant medication (nortriptyline) to 
treat the depression [9] and the other used cognitive 
behavior therapy (CBT) [10]. In both studies, the interven­
tion reduced depression and improved glucose control 
relative to the control condition. However, there was no 
evidence that reducing depression led to improved adher­
ence, as measured by the use of home blood glucose 
monitoring. In fact, patients who participated in CBT 
showed worsening in their adherence to glucose monitoring 
relative to the control condition. 
Thus, based on these few studies, there is no evidence to 
support the hypothesis that adherence mediates the relation­
ship between depression and outcome. Further study with 
objective measures of adherence, clear criteria for defining 
adherence, and assessments of adherence to a variety of 
different behaviors is needed. 
An alternative model 
As discussed above, there are many studies showing a 
correlation between depressive symptomatology and behav­
ior. These results are often interpreted as implying that 
depression causes poor adherence. It is important to recog­
nize that in some situations, the direction of the relation may 
be reversed — the behaviors may precede and influence the 
mood state (Fig. 2). Hence by changing the behavior, it may 
be possible to change the mood state (rather than vice 
versa). Further, changing the behavior may influence the 
health outcome. There may also be indirect effects such that 
changing the behavior may influence health outcome 
through an effect on mood. 
Fig. 2. Alternative model of the relationship between behavioral adherence, 
depression, and health outcome. 
As an example consider exercise. A number of studies 
have shown an association between physical activity and 
depression [11]. Although depression may lead to more 
sedentary behavior, there are also several studies suggest­
ing that low physical activity precedes, and is a risk factor 
for, subsequent depression. In the Harvard Alumni study, 
for example, physical activity level reported in 1962 and 
1966 was associated with increased risk of physician-
diagnosed depression 23–27 years later [12]. Compared 
to those men who reported < 1000 kcal/week of physical 
activity, those who reported 1000–2499 kcal/week had a 
17% reduction in risk of clinically recognized depression 
and those who were most active ( > 2500 kcal/week) had a 
28% reduction in risk. 
Moreover, increasing exercise is an effective treatment 
for depression. In a recent study [13], 156 adults with major 
depressive disorder were randomly assigned to an exercise 
condition (three supervised exercise sessions per week for 
16 weeks) or to depression medication (Sertraline), or to the 
combination of medication plus exercise. Remission rates 
after 4 months were comparable in the three conditions 
(60.4% of patients in the exercise group; 65.5% in the 
medication group; and 68.8% in the combined group had 
remission). Recently, 10-month follow-up data were pre­
sented for 133 of the original 156 patients [11]. Patients in 
the exercise group had significantly lower relapse rates than 
subjects in the medication group. In addition, exercising on 
one’s own during follow-up was strongly associated (odds 
ratio = 0.49, P =.0009) with reduced risk of a diagnosis of 
depression at the end of 10 months. 
Obesity and weight control is also an interesting 
example. Depressive symptomatology, assessed at the start 
of a weight loss program, is not strongly or consistently 
associated with weight loss outcome, although in some 
studies, depression levels at baseline are associated with 
early termination of treatment. In contrast, participation in 
a behavioral weight loss program appears to produce 
marked, long-term improvements in depressive symp­
tomatology. Patients report improvements in mood state 
within the first few weeks of a weight loss program, with 
improvements over the initial 6-month program apparently 
related to the magnitude of weight loss. However, interest­
ingly, when participants are followed over time, improve­
ment in mood persists even if the weight is regained. 
Foster et al. [14] studied 48 patients before and after a 
6-month behavioral weight loss program and again at a 
58-month follow-up. Body weight averaged 105.8, 84.7, 
and 109.4 kg at these three time points, respectively. Beck 
Depression Inventory scores were 12.7, 6.0, and 9.3 for the 
three time points, and the follow-up levels were signific­
antly below ( P =.006) baseline. At follow-up, weight loss 
was unrelated to changes in mood. These data suggest that 
some aspect of the program (possibly the exercise com­
ponent, the social support, or the cognitive behavioral 
approach), rather than weight loss per se, produced a 
positive change in mood state. 
Changing physical activity level and/or weight can affect 
health outcomes directly and may also affect health out­
comes via improvements in depression. There is extensive 
literature showing that physical activity level and body 
weight are related to risk of developing diabetes and/or 
cardiovascular disease and to mortality. Thus, changing 
these behaviors may have a far more dramatic effect on 
health outcomes than changing mood state. 
Conclusion and future research directions 
In conclusion, it is clear that there is a correlation 
between depressive symptomatology and adherence behav­
iors. It is time that the field moves beyond this simple fact 
and begins to ask why this correlation occurs and how it 
affects health outcomes. Below are some suggestions for 
future research. 
1. Better methods to assess adherence 
One of the major limitations in this field is the 
difficulty of setting criteria for defining adherence and 
objectively measuring this construct, especially adherence 
to complex behaviors such as diet. As noted above, self-
reported behavior may be particularly problematic and 
potentially biased in depressed patients. Better ways to 
objectively assess key behaviors, such as diet and physical 
activity, are clearly needed. It is also important to establish 
criteria for determining when a patient is adherent, a task 
made more difficult by the fact that many behavioral 
prescriptions are given in general terms (e.g., ‘‘increase 
your physical activity’’). It is also important to carefully 
specify the behaviors that we expect might be related to 
outcome. For example, rather than simply assessing fre­
quency of self-monitoring of glucose, it is important to 
assess the use of SMBG information to regulate other 
aspects of the regimen. 
2. Research on whether adherence mediates the relationship 
between depression and outcome 
Future research should more specifically address the 
question of whether adherence mediates the relationship 
between depression and outcomes. Baron and Kenny [15] 
have proposed a methodological approach to studying 
mediators that would be helpful in this regard. Studies of 
the treatment of depression, where treatment improves 
health outcomes, should include objective measures of 
adherence. A variety of different aspects of adherence 
should be assessed (including adherence to both the depres­
sion and medical treatment regimens) since adherence to 
various components of the regimen are often not related to 
each other, and the combination of behaviors may be more 
strongly related to outcome than any one behavior [2]. 
Again, if the relationship between improvements in depres­
sion and health outcome is positive, researchers should 
determine whether this relationship is partially or fully 
explained by adjusting for adherence. 
3. Research to improve adherence in depressed patients 
Another approach to understanding the role of adher­
ence in mediating the relationship between depression and 
outcome is to develop strategies to improve adherence to 
the medical treatment regimen for depressed patients and 
then determine whether the increased adherence improves 
health outcome. For example, simplifying the regimen or 
providing adherence reminders may be particularly helpful 
for patients with depression. Strategies that empower 
patients and encourage the development of an alliance 
between patients and providers may also improve adher­
ence. In addition, examining whether improving adherence 
to pharmacologic or psychological treatment for depres­
sion has an effect on health outcome is an important area 
of inquiry. 
4. Comparing interventions that are aimed at reducing 
depression with interventions that focus on behaviors such 
as exercise and weight control 
Ultimately, the most important question is whether 
health outcomes are improved more dramatically by 
targeting depression or by targeting other behaviors that 
appear to be more directly related to the outcome 
(Fig. 2). Physical activity and weight loss have been 
shown to be related to the risk of developing diabetes 
and appear important in its treatment. Future research 
should determine whether diabetes health outcomes (e.g., 
glycosylated hemoglobin, lipids, blood pressure) are 
better addressed by reducing depression or by focussing 
on behaviors directly related to health outcome. Redu­
cing depression with techniques such as CBT or med­
ication may improve health outcome through several 
mechanisms, including, perhaps, increased physical activ­
ity and adherence to dietary recommendations. Alterna­
tively, it may be more effective to directly focus on 
increasing physical activity or promoting weight loss; 
these behavior changes may simultaneously affect both 
depression and health outcome. 
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